Keye L. Wong, MD

(941) 924-0303 (Office)

Retina Associates of Sarasota
3920 Bee Ridge Road
Bldg. D

Sarasota, FL 34233 , US map


http://www.retinasarasota.com


Education and training

College
Harvard College, Cambridge, MA, USA
Medical School
Rush Medical College, Chicago, IL USA
Internship
University of Hawaii, Honolulu, HI USA
Ophthalmology residency
Duke University Eye Center, Durham, NC USA
Retinal fellowship
Pacific Presbyterian Medical Center, San Francisco, CA USA

Biography

CURRICULUM VITAE

KEYE LUC WONG, M.D.

Born: Honolulu, Hawaii

Address: Retina Associates of Sarasota
3920 Bee Ridge Road, Bldg. D
Sarasota, Florida 34233
(941) 924-0303
(941) 924-0309 FAX

EDUCATION

1973 Punahou High School
Honolulu, Hawaii

1973 - 1977 Harvard College
B.A. Biochemistry, Magna Cum Laude
Cambridge, Massachusetts

1977 - 1982 Rush Medical University
M.D.
Chicago, Illinois

1982 - 1983 University of Hawaii Integrated Transitional Program
Internship
Honolulu, Hawaii

1983 - 1986 Duke University Eye Center
Ophthalmology Residency
Durham, North Carolina

1987 - 1988 Pacific Presbyterian Medical Center
Vitreo-Retinal Fellowship
San Francisco, California

ACADEMIC AFFILIATION

Current Assistant Clinical Professor
Department of Ophthalmology
University of South Florida School of Medicine

EMPLOYMENT RECORD

10/80 - 6/81 San Francisco General Hospital
Research Associate
San Francisco, California

8/83 - 10/83 Kuzell Institute for Arthritis Research
Research Associate
San Francisco, California

11/86 - 6/87 Kaiser-Permanente Medical Center
Staff Ophthalmologist
Honolulu, Hawaii

7/88 - 10/89 Kaiser-Permanente Medical Group
Retina Consultant
Sacramento, California

10/89 – 12/07 Sarasota Retina Institute
Sarasota, Florida

12/07 – Current Retina Associates of Sarasota
Sarasota, Florida

HONORS & AWARDS

Presidential Scholar Harvard College 1973

Achievement Award American Academy of Ophthalmology 1999

Honor Award Vitreous Society 2002

PROFESSIONAL SOCIETIES

American Academy of Ophthalmology
American Society of Retinal Specialists
Chinese American Ophthalmologic Society
Fellow of American College of Surgeons
Florida Medical Association
Sarasota County Medical Society
Retina Society
Western Association for Vitreoretinal Education


PUBLICATIONS

1. 1981 Wong KL, Ai E, Jones JV, & Young D: Visual loss as the initial symptom of systemic lupus erythematosus. Am J Ophthalmol 92:238

2. 1983 Wong KL & Howes EL Jr.: Intraocular injection of prostaglandins: Modification of response to circulating bacterial endotoxin. Arch Pathology 101:275 (1983).

3. 1984 Rosenbaum JT, Wong KL, Perez JD, Raymond W, Howes EL Jr.: Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor. Invest Ophthalmol Vis Sci. 25:1184 (1984).

4. 1985 Howes EL Jr., Wong KL, Hartiala KT, Webster RO, Rosenbaum JT: Complement and polymorphonuclear leukocytes do not determine the vascular permeability induced by intraocular LPS. Am J Path 118:35 (1985).

5. 1988 Ai E., Wong KL: Ophthalmic manifestations of AIDS. Ophthalmol Clin of North Amer. 1:53 (1988).

6. 1999 Olk RJ, Fribert TR, Stickney KL, Akduman L, Wong KL, Chen MC, Levy MH, Garcia CA, Morse LS: Therapeutic Benefits of Infrared (810 nm) Diode Laser Macular Grid Photocoagulation in Prophylactic Treatment of Nonexudative Age-Related Macular Degeneration: Two-year Results of a Randomized Pilot Study. Ophthalmology 106: 2082.(1999).

7. 2001 Wong KL, Grabow HB: Simplified Technique to Remove Posteriorly Dislocated Lens Implants. Archives of Ophthalmology. 119:273 (2001).

8. 2006 Friberg TR, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S, PTAMD Study Group: Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810—Nanometer Laser to Eyes with Drusen. Unilaterally Elilgible Patients. Ophthalmology 113:612 (2006).

Hudson HL, Land SS, Heir JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF, IMT-002 Study Grouop: Implantable Miniature Telescope for the Treatment of Visual Acuity Loss Resulting from End-Stage Age-Related Macular Degeneration: 1-year Results. Ophthalmology 113:1987 (2006).

PKC-DRS 2 Group. Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy. Ophthalmology 113:2221 (2006).

9. 2007 Diabetic Retinopathy Clinical Research Network: Diurnal Variation in Retinal Thickening Measurement by Optical Coherence Tomography in Center-Involved Diabetic Macular Edema. Arch Ophthalmol 124:1701 (2007).

Diabetic Retinopathy Clinical Research Network: Relationship Between Optical Coherence Tomography-Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema. Ophthalmology 114:525 (2007).

Dexamethasone DDS Phase II Study Group: Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients with Persistent Macular Edema. Arch Ophthalmol 125:309 (2007).

10. 2009 The SCORE Study Research Group: A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Observation to Treat Vision Loss Associated with Macular Edema Secondary to Central Retinal Vein Occlusion. The Standard Card vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5. Arch Ophthalmol 127:1101 (2009).

The SCORE Study Research Group: A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Standard Care to Treat Vision Loss Associated with Macular Edema Secondary to Branch Retinal Vein Occlusion. The Standard Card vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6. Arch Ophthalmol 127:1115 (2009).

RESEARCH

1996 – 2004 Principal Investigator
Prophylactic Diode Laser Photocoagulation for the Prevention of Choroidal Neovascularization in Age-Related Macular Degeneration.

1998 – 2003 Principal Investigator
Phase III Safety & Efficacy Study of Vitrase (Hyaluronidase) for Ophthalmic Intravitreal Injection for Clearance of Severe Vitreous Hemorrhage. Protocol # VIT-02-08961X

1999 – 2004 Principal Investigator
Vitrectomy for Branch Retinal Vein Occlusion Pilot Study: A Prospective Multicenter Clinical Trial.

1999 – 2000 Sub-investigator
Visudyne in Age-Related Macular Degeneration (VAM) Trial

2000 – 2001 Sub-investigator
Neuroprotection in Optic Neuropathy. Protocol #190342-010-00

2000 – 2004 Principal Investigator
Transpupillary Thermotherapy of Occult Subfoveal CNV in Patients with AMD (The TTT4CNV Clinical Trial)

2001 – 2005 Principal Investigator
Protein kinase cß inhibitor – diabetic retinopathy study 2 (PKC-DRS2). A phase III clinical trial. Protocol #B7A-MC-MBCM

2001 – 2003 Principal Investigator
A Phase 2 Randomized, Muticenter, Dose-Ranging, Controlled, Parallel-Group Trial to Assess the Safety & Efficacy of Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in the Treatment of Persistent Macular Edema. Protocol #OC103-06-03.

2002 - 2003 Principal Investigator
A 3-month Randomized, Placebo-controlled, Double Masked, Multicenter, Phase II Study of the Effects of Adjunctive Diclofenac Therapy after Visudyne PDT in Patients with Predominantly Classic Subfoveal CNV Secondary to AMD. Protocol #CBPD952A2201

2002 – 2007 Principal Investigator
A Phase II/III Randomized, Double-masked, Controlled, Dose Ranging, Multicenter Comparative Trial, in Parallel Groups, to Establish the Safety & Efficacy of Intravitreal Injections of EYE001 (anti-VEGF pegulated aptamer) Given Every 7 Weeks for 54 Weeks in Patients with Exudative AMD.

2002 – 2005 Principal Investigator
A Randomized, Placebo-Controlled, Double-Masked, Multicenter Phase III Study of the Effect of Visudyne in Occult with No Classic Subfoveal Choroidal Neovascularization (CNV) secondary to AMD. (AMD:Visudyne in Occult – VIO). Protocol # BPD OCR 013

2003 – 2006 Principal Investigator
A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema. Protocol DRCR - A

2003 – 2007 Principal Investigator
A Prospective Multicenter Clinical Trial of the VisionCare Ophthalmic Technologies Implantable Miniature Telescope (IMT) in Patients with Central Vision Impairment Associated with Age-Related Macular Degeneration, Stargardt’s Macular Dystrophy, and no other Maculopathies. Protocol #: IMT-002.

2004 – 2006 Principal Investigator
A Randomized trial comparing Intravitreal Triamcinolone Acetate and Laser Photocoagulation for Diabetic Macular Edema (DRCR - B)

2004 – 2005 Principal Investigator
Reduction in the Occurrence of Center-Threatening Diabetic Macular Edema (B7A-MC-MBDL).

2004 – 2005 Principal Investigator
Temporal Variation in Optical Coherence Tomography Measurements of Retinal Thickening in Diabetic Macular Edema (DRCR – C)

2004 – 2005 Principal Investigator
A Phase II Prospective, Randomized, Double-Masked, Sham Controlled, Dose-Ranging, Multi-Center Trial to Assess The Effect of Pegaptanib Sodium on Foveal Thickening in Patients with Exudative Subfoveal Age-Related Macular Degeneration (AMD). (EOP 1009)

2004 – 2006 Principal Investigator
A Phase 3B, Randomized, Active Controlled, Double-Masked, Single Dummy, Multi-Center Comparative Trial, in Parallel Groups to Compare the Safety and Efficacy of Intravitreous Injections of Macugen given every 6 weeks Plus Sham PDT verses PDT with Visudyne. (EOP1012)

2004 – 2006 Principal Investigator
A Phase 2, Multi-center, Randomized, Controlled, Masked Study of the Effects of Squalamine Lactate in Combination with Visudyne in Patients with Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration.

2004 – 2007 Principal Investigator
The Standard of Care vs. Corticosteroid for REtinal Vein Occlusion (SCORE) Study.

2005 – 2007 Principal Investigator
A Phase II, Randomized, Double-Masked, Controlled, Dose Comparison Study of Cand5 for Intravitreal Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated with Wet Age-Related Macular Degeneration

2005 – 2006 Principal Investigator
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema (DRCR – E)

2010 – Current Principal Investigator
DRCR.net Protocol N
NATIONAL CONFERENCE PRESENTATIONS

1. Wong KL, Rosenbaum JT: Complement (C5)-derived aqueous humor chemotactic activity in a model of acute anterior uveitis. ARVO. May 1984

2. Wong KL, Fung WE, & Allen AW: Results and complications of pneumatic retinopexy. Vitreous Society. December 1987

3. Wong KL, Fung WE, & Allen AW: Bilateral, recurrent vitritis in an apparently healthy 42-year old male. West Coast Retina Study Club. March 1988

4. Wong KL: Laser photocoagulation for chorioretinal disease: Selection of wavelength. The 4th Annual Sarasota Vitreo-Retinal Update Course. February 1990

5. Wong KL: Pneumatic retinopexy and the use of intraocular gas in vitreoretinal surgery. The 4th Annual Sarasota Vitreo-Retinal Update Course. February 1990

6. Wong KL, Levy MH, Chen MC: Optic nerve sheath fenestration for progressive optic neuropathies. Western Association for Vitreoretinal Education. July 1990

7. Wong KL, Chen MC, Levy MH: Subretinal fibrosis and uveitis. Western Association for Vitreoretinal Education. July 1990

8. Wong KL: Selection of laser wavelength: From dye to diode. The 5th Annual Sarasota Vitreo-Retinal Update Course. February 1991

9. Wong KL: YAG capsulotomy and the risk of retinal detachment. The 5th Annual Sarasota Vitreo-Retinal Update Course. February 1991

10. Wong KL: Post-op pain medications following private practice vitreo-retinal surgery. Western Association for Vitreoretinal Education. July 1991

11. Wong KL: Mycobacterium endophthalmitis. Western Association for Vitreoretinal Education. July 1991

12. Wong KL: Vitamin therapy in the management of macular degeneration. The 6th Annual Sarasota Vitreo-Retinal Update Course. February 1992

13. Wong KL: Cocaine retinopathy. Western Association for Vitreoretinal Education. July 1992

14. Wong KL: Selection of laser delivery system: Slit lamp vs. Indirect. The 7th Annual Sarasota Vitreo-Retinal Update Course. January 1993.

15. Wong KL: Effect of needle gauge on fluorescein transit time. The 8th Annual Sarasota Vitreo-Retinal Update Course. February 1994

16. Wong KL: New treatment options in the management of vein occlusions. The 8th Annual Sarasota Vitreo-Retinal Update Course. February 1994

17. Wong KL: Subretinal mass following ocular trauma. Western Association for Vitreoretinal Education. July 1994

18. Wong KL: Optic nerve sheath fenestration in the management of central retinal vein occlusion. Retina Grand Rounds University of South Florida. November 1994

19. Wong KL: Macular degeneration: A stereoscopic presentation. The 9th Annual Sarasota Vitreo-Retinal Update Course. February 1995

20. Wong KL: Aspirin for retinal and subretinal vascular diseases: Helpful or harmful? The 9th Annual Sarasota Vitreo-Retinal Update Course. February 1995

21. Wong KL: CMV retinitis: Screening and management. 15th Congress of the Asia-Pacific Academy of Ophthalmology. March 1995

22. Wong KL: Anticoagulants and ARMD. Nantucket Retina Meeting. July 1995

23. Wong KL: Anticoagulants and the risk of hemorrhage in ARMD. Vitreous Society. August 1995

24. Wong KL: Aspirin and Warfarin as Risk Factors for Hemorrhage in Age-Related Macular Degeneration. American Academy of Ophthalmology Annual Meeting. October 1995.

25. Wong KL: Adjunctive agents in macular hole surgery. The 10th Annual Sarasota Vitreo-Retinal Update Course. February 1996.

26. Wong KL: Does cataract extraction aggravate ARMD? The 10th Annual Sarasota Vitreo-Retinal Update Course. February 1996.

27. Wong KL: Inflammatory subretinal mass following trauma. Western Retina Study Club. March 1996.

28. Wong KL: Anticoagulants and aphakia as risk factors for hemorrhage in ARMD. Western Association for Vitreo-Retinal Education. July 1996.

29. Wong KL: Macular hole surgery: An update. Western Association for Vitreo-Retinal Education. July 1996.

30. Wong KL: Cystoid Macular Edema Following CMV Retinitis in a non-AIDS Patient. Western Association for Vitreo-Retinal Education. July 1996.

31. Wong KL: A comparison of cryoprecipitate vs. plasma for macular hole surgery. Nantucket Retina Meeting. July 1996.

32. Wong KL: Subretinal inflammation following ocular trauma. Wills Eye Hospital Fluorescein Conference. September 1996.

33. Wong KL: Does cataract extraction aggravate ARMD? Wills Eye Hospital Vitreoretinal Update. September 1996.

34. Wong KL: Cataract Extraction as a Risk Factor for Exudative ARMD. American Academy of Ophthalmology Annual Meeting. October 1996.

35. Wong KL: Stereoscopic concepts in vitreo-retinal diseases. Course at Joint Commission of Allied Health Professionals in Ophthalmology Annual Meeting. October 1996.

36. Wong KL: Macular Pucker Surgery. Project Orbis. November 1996.

37. Wong KL: Internet Resources for Fellowship-Trained Dummies. The 11th Annual Sarasota Vitreo-Retinal Update Course. February 1997.

38. Wong KL: Update on Macular Degeneration. Visiting Professor Pacific Presbyterian Medical Center. July 1997.

39. Wong KL: Cataract Extraction as a Risk Factor for Exudative AMD. Vitreous Society. New Orleans. September 1997.

40. Wong KL: Stereoscopic Concepts in Macular Diseases. JCAHPO Annual Meeting. San Francisco. October 1997.

41. Wong KL: Retinal Manifestations of Temporal Arteritis. The 12th Annual Sarasota Vitreo-Retinal Update Course. February 1998.

42. Wong KL: Diode Laser Photocoagulation for Prevention of CNV. The 12th Annual Sarasota Vitreo-Retinal Update Course. February 1998.

43. Wong KL: Propylactic Therapy for AMD. Vitreous Society. July 1998.

44. Wong KL: Temporal Arteritis in a Retinal Private Practice. Nantucket Retina. July 1998.

45. Wong KL: Senior Instructor of Diabetes 2000 Workshop. American Academy of Ophthalmology. New Orleans. November 1998.

46. Wong KL: New Management Options for Branch Vein Occlusions. The 13th Annual Sarasota Vitreo-Retinal Update Course. February 1999.

47. Wong KL: Subretinal Retinal Infiltrates. 7th Annual Western Association for Vitreoretinal Education Meeting. July 1999.

48. Wong KL: A New Technique of Management of Dislocated Plate Haptic IOL’s. Nantucket Retina. July 1999.

49. Wong KL: Management of Dislocated Silicone Plate IOL’s. Vitreous Society. September 1999

50. Wong KL: Senior Instructor of Diabetes 2000 Workshop. American Academy of Ophthalmology. Orlando. November 1999.

51. Wong KL: Senior Instructor of Diabetes 2000 Workshop. American Academy of Ophthalmology. Dallas. November 2000.

52. Wong KL: Visudyne Photodynamic Therapy: Indications and Techniques. The 15th Annual Sarasota Vitreo-Retinal Update Course. February 2001.

53. Wong KL: Branch Vein Occlusion Sheathotomy. The 15th Annual Sarasota Vitreo-Retinal Update Course. February 2001.

54. Wong KL: Optic Nerve Sheath Fenestration for CRVO: A Retrospective Review. 8th Annual Western Association for Vitreo-Retinal Education Meeting. July 2001.

55. Wong KL: Optic Nerve Sheath Fenestration for Acute CRVO. Nantucket Retina. July 2001.

56. Wong KL: Senior Instructor of Diabetes 2001 Workshop. American Academy of Ophthalmology. New Orleans. November 2001.

57. Wong KL: Management of Proliferative Diabetic Retinopathy. American Academy of Ophthalmology. New Orleans. November 2001.

58. Wong KL: Diagnosis and Treatment of Proliferative Diabetic Retinopathy. American Academy of Ophthalmology. New Orleans. November 2001.

59. Wong KL: Management of Retinal Vascular Occlusions. The 16th Annual Sarasota Vitreo-Retinal Update Course. February 2002.

60. Wong KL: Impact of Photodynamic Therapy on a Vitreoretinal Practice in a Retirement Community. Nantucket Retina. July 2002.

61. Wong KL: A Novel Technique for Removing Dislocated Posterior Chamber Lens Implants. Advanced Innovations in Medicine. Aruba. September 2002.

62. Wong KL: The Potential Cost Savings by Using a Butterfly Needle with Short Tubing. Vitreous Society. September 2002.

63. Wong KL: Senior Instructor of Diabetes 2002 Workshop. American Academy of Ophthalmology. Orlando. October 2002.

64. Wong KL: Management of Diabetic Macular Edema. American Academy of Ophthalmology. Orlando. October 2002.

65. Wong KL, MC Chen, MH Levy. Optic Nerve Sheath Fenestration for CRVO: A 10-year Retrospective Review. Poster Presentation at American Academy of Ophthalmology. Orlando. October 2002.

66. Wong KL: Current Management of Macular Edema. The 17th Annual Sarasota Vitreo-Retinal Update Course. February 2003.

67. Johnston RH, Wong KL, Chen MC, Levy MH. Surgical Displacement of Submacular Hemorrhage from macular Degeneration with Vitrectomy, Subretinal Injection of tPA, Patial Gas-Fluid Exchange and Post-Operative Upright, Alternating with Prone Positioning. Association for Research in Vision and Ophthalmology. Ft. Lauderdale. May 2003.

68. Wong KL & Johnston RH: tPA for Subretinal Hemorrhage in AMD: Modification of Technique. Nantucket Retina July 2003.

69. Wong KL: Treatment of Macular Degeneration: Current and Future Management. Curso Avancado do Diagnostico e Tratamento. Sao Paulo, Brazil. August 2003.

70. Wong KL: Plaquenil Toxicity – Case Presentation. Retina Society. Chicago. September 2003.

71. Johnston RH, Wong KL, Chen MC, Levy MH. Endophthalmitis Following Intravitreal triamcinolone Injection: A Report of 7 Cases. American Academy of Ophthalmology. Anaheim. November 2003.

72. Wong KL: Management of Diabetic Macular Edema. American Academy of Ophthalmology. Anaheim. November 2003.

73. Wong KL: Senior Instructor of Diabetes 2003 Workshop. American Academy of Ophthalmology. Anaheim. November 2003.

74. Wong KL: ABC’s of OCT. The 18th Annual Sarasota Vitreo-Retinal Update Course. February 2004.

75. Wong KL: Inflammatory Subretinal Mass – Case Presentation. Midwest Ocular Angiography Conference. Jackson Hole,. June 2004.

76. Wong KL: Senior Instructor of Diabetes 2004 Workshop. American Academy of Ophthalmology. New Orleans. October 2004.

77. Wong KL: Management of Diabetic Macular Edema and Proliferative Diabetic Retiniopathy. American Academy of Ophthalmology. New Orleans. October 2004

78. Wong KL: tPA-Assisted Pneumatic Hemodisplacement. The 19th Annual Sarasota Vitreo-Retinal Update Course. February 2005.

79. Wong KL: tPA-Assisted Pneumatic Hemodisplacement: When is it too late to evacuate subretinal hemorrhage? Aegean Retina. Crete, Greece. July 2005.

80. Wong KL: tPA-assisted pneumatic hemodisplacement: What is the role of the gas bubble? American Society of Retinal Specialists Annual Meeting. Montreal. July 2005.

81. Wong KL: tPA-Assisted Pneumatic Hemodisplacement: When is it too late to evacuate subretinal hemorrhage? Retina Society. San Diego. September 2005.

82. Wong KL: Senior Instructor of Diabetes 2005 Workshop. American Academy of Ophthalmology. Chicago. October 2005.

83. Wong KL: Management of Diabetic Macular Edema. American Academy of Ophthalmology. Chicago. October 2005.

84. Wong KL: Does cataract surgery cause AMD progression? The 20th Annual Sarasota Vitreo-Retinal Update Course. February 2006.

85. Wong KL: Limited macular translocation surgery: What have we learned? Nantucket Retina. July 2006.

86. Wong KL: When is it too late to evacuate submacular hemorrhage in AMD? American Society of Retinal Specialists Annual Meeting. Cannes. September 2006.

87. Wong KL: tPA-assisted pneumatic hemodisplacement: What is the role of the gas bubble? Retina Society Annual Meeting. Cape Town. October 2006.

88. Wong KL: Senior Instructor of Diabetes 2006 Workshop. American Academy of Ophthalmology. Las Vegas. November 2006.

89. Wong KL: Management of Diabetic Macular Edema. American Academy of Ophthalmology. Las Vegas. November 2006.

90. Wong KL: In the era of OCT does macular edema need to be “clinically significant.” The 21st Annual Sarasota Vitreo-Retinal Update Course. February 2007.

91. Wong KL: tPA-assisted pneumatic hemodisplacement: What is the role of the gas bubble? Western Association for Vitreoretinal Education. Maui. July 2007.

92. Wong KL: Does vision improvement lag OCT improvement in AMD? Nantucket Retina. July 2007.

93. Wong KL: Diagnosis and Management of NPDR & CSME. American Academy of Ophthalmology. New Orleans. November 2007.

94. Wong KL: Senior Instructor of Diabetes 2007 Workshop. American Academy of Ophthalmology. New Orleans. November 2007.

95. Wong KL: Does vision improvement lag OCT improvement in AMD? Retina Society. Scottsdale, Arizona. September 2008.

96. Wong KL: Does vision improvement lag OCT improvement in AMD: American Society of Retina Specialists. Maui. October 2008.

97. Wong KL: Diagnosis and Management of NPDR & CSME. American Academy of Ophthalmology. Atlanta. November 2008.

98. Wong KL: Senior Instructor of Diabetes 2008 Workshop. American Academy of Ophthalmology. Atlanta. November 2008.

99. Wong KL: Are the DRS & ETDRS Still Standard of Care? The Florida Retina Symposium Sarasota 2009. Sarasota. March 2009.

100. Wong KL & Niffenegger JH: Diagnosis of PVD. Masters at the WAVE. Maui. July 2009.

101. Wong KL: Management of Diabetic Retinopathy in 2009. Nantucket Retina. July 2009.

102. Wong KL: Diagnosis and Management of NPDR & CSME. American Academy of Ophthalmology. San Francisco. October 2009.

103. Wong KL: Senior Instructor of Diabetes 2009 Workshop. American Academy of Ophthalmology. San Francisco. October 2009.

104. Wong KL: OCT Validation of PVD: The Florida Retina Symposium Orlando 2010. Orlando. March 2010.

105. Wong KL: Vitreous Semantics. The 6th Annual Rush Alumni and Resident’s Day. Chicago. June 9, 2010.

106. Wong KL: CSME in Pregnancy: A case report and literature review. Florida Society of Ophthalmology Annual Meeting. Orlando. June 27, 2010.

107. Wong KL: CSME in Pregnancy: A case report and literature review. Midwest Ophthalmic Angiography Conference. Jasper, Canada. August 2010.

108. Wong KL: Does OCT Accurately Predict PVD? Retina Society. San Francisco. September 25, 2010.

109. Wong KL: Major Findings of the DRS & ETDRS: Diabetes 2010. American Academy of Ophthalmology. Chicago. October 2010.

110. Wong KL: Senior Instructor of Diabetes 2010 Workshop. American Academy of Ophthalmology. Chicago. October 2010.

111. Wong KL:Is our traditional management of diabetic retinopathy evidenced-based?: The Florida Retina Symposium Sarasota 2011. Longboat Key. March 2011.

112. Wong KL: Does “Treat and Extend” increase the Risk of “massive” subretinal hemorrahge?. The 7th Annual Rush Alumni and Resident’s Day. Chicago. June 10, 2011.

113. Wong KL: Evidenced-based management of diabetic retinopathy. Western Association for Vitreo-Retinal Education. Maui July 2011.

114. Wong KL: Does “prn” VEGF suppression increase the risk of subretinal hemorrhage? Nantucket Retina. July 2011.

Keye L. Wong, MD

Academic appointments

  • Assistant Clinical Professor University of South Florida

Hospital appointments

  • Sarasota Memorial Hospital